Improving the solubility rate of fursemide in biological media by using self-emulsifying systems and preparing them in the form of tablets in order to improve its bioavailability and reduce variations in treatment between individuals. Fursemide is classified as a fourth-class drug according to the biopharmaceutical classification due to its limited solubility and permeability.
